Nexalin Ownership 2024 | Who Owns Nexalin Now?

Overview RevenueFinancials Chart

Institutional Ownership

3.71%

Insider Ownership

14.56%

Retail Ownership

81.73%

Institutional Holders

13.00

Nexalin Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
MORGAN STANLEY	0.80%	-	59,805	59,805	100.00%	101,070	Jun 30, 2024
CVI HOLDINGS, LLC	0.75%	0.08%	55,462	55,462	100.00%	93,731	Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC	0.59%	-	44,062	5,196	13.37%	74,464	Jun 30, 2024
ATRIA WEALTH SOLUTIONS, INC.	0.52%	0.00%	38,413	38,413	100.00%	64,918	Jun 30, 2024
VANGUARD GROUP INC	0.43%	-	31,780	31,780	100.00%	53,708	Jun 30, 2024
STATE STREET CORP	0.23%	-	16,800	16,800	100.00%	28,392,000	Jun 30, 2024
SQUAREPOINT OPS LLC	0.17%	-	12,631	12,631	100.00%	21,346	Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)	0.13%	0.00%	9,870	791	8.71%	16,680	Jun 30, 2024
UBS GROUP AG	0.05%	-	4,036	-132	-3.17%	6,821	Jun 30, 2024
ADVISOR GROUP HOLDINGS, INC.	0.04%	-	3,000	3,000	100.00%	5,070	Jun 30, 2024
STONE HOUSE INVESTMENT MANAGEMENT, LLC	0.00%	0.00%	357	357	100.00%	603	Jun 30, 2024
BANK OF AMERICA CORP /DE/	0.00%	-	46	46	100.00%	78	Jun 30, 2024
WELLS FARGO & COMPANY/MN	-	-	-	-44	-100.00%	-	Jun 30, 2024

Nexalin's largest institutional shareholder is MORGAN STANLEY, holding 0.80% of the company's total share outstanding, currently valued at $101.07K. The top 10 institutional shareholders own together 3.71% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
CVI HOLDINGS, LLC	0.75%	0.08%	55,462	55,462	100.00%	93,731	Jun 30, 2024
ATRIA WEALTH SOLUTIONS, INC.	0.52%	0.00%	38,413	38,413	100.00%	64,918	Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)	0.13%	0.00%	9,870	791	8.71%	16,680	Jun 30, 2024
STONE HOUSE INVESTMENT MANAGEMENT, LLC	0.00%	0.00%	357	357	100.00%	603	Jun 30, 2024
SQUAREPOINT OPS LLC	0.17%	-	12,631	12,631	100.00%	21,346	Jun 30, 2024
ADVISOR GROUP HOLDINGS, INC.	0.04%	-	3,000	3,000	100.00%	5,070	Jun 30, 2024
MORGAN STANLEY	0.80%	-	59,805	59,805	100.00%	101,070	Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC	0.59%	-	44,062	5,196	13.37%	74,464	Jun 30, 2024
UBS GROUP AG	0.05%	-	4,036	-132	-3.17%	6,821	Jun 30, 2024
STATE STREET CORP	0.23%	-	16,800	16,800	100.00%	28,392,000	Jun 30, 2024
VANGUARD GROUP INC	0.43%	-	31,780	31,780	100.00%	53,708	Jun 30, 2024
BANK OF AMERICA CORP /DE/	0.00%	-	46	46	100.00%	78	Jun 30, 2024
WELLS FARGO & COMPANY/MN	-	-	-	-44	-100.00%	-	Jun 30, 2024

The largest Nexalin shareholder by % of total assets is CVI HOLDINGS, LLC. The company owns 55.46K shares of Nexalin (NXL), representing 0.08% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
MORGAN STANLEY	0.80%	-	59,805	59,805	100.00%	101,070	Jun 30, 2024
CVI HOLDINGS, LLC	0.75%	0.08%	55,462	55,462	100.00%	93,731	Jun 30, 2024
ATRIA WEALTH SOLUTIONS, INC.	0.52%	0.00%	38,413	38,413	100.00%	64,918	Jun 30, 2024
VANGUARD GROUP INC	0.43%	-	31,780	31,780	100.00%	53,708	Jun 30, 2024
STATE STREET CORP	0.23%	-	16,800	16,800	100.00%	28,392,000	Jun 30, 2024
SQUAREPOINT OPS LLC	0.17%	-	12,631	12,631	100.00%	21,346	Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC	0.59%	-	44,062	5,196	13.37%	74,464	Jun 30, 2024
ADVISOR GROUP HOLDINGS, INC.	0.04%	-	3,000	3,000	100.00%	5,070	Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)	0.13%	0.00%	9,870	791	8.71%	16,680	Jun 30, 2024
STONE HOUSE INVESTMENT MANAGEMENT, LLC	0.00%	0.00%	357	357	100.00%	603	Jun 30, 2024
BANK OF AMERICA CORP /DE/	0.00%	-	46	46	100.00%	78	Jun 30, 2024
WELLS FARGO & COMPANY/MN	-	-	-	-44	-100.00%	-	Jun 30, 2024
UBS GROUP AG	0.05%	-	4,036	-132	-3.17%	6,821	Jun 30, 2024

As of Jun 30 2024, Nexalin's largest institutional buyer is MORGAN STANLEY. The company purchased 59.80K stocks of NXL, valued at $101.07K.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
UBS GROUP AG	0.05%	-	4,036	-132	-3.17%	6,821	Jun 30, 2024
WELLS FARGO & COMPANY/MN	-	-	-	-44	-100.00%	-	Jun 30, 2024
BANK OF AMERICA CORP /DE/	0.00%	-	46	46	100.00%	78	Jun 30, 2024
STONE HOUSE INVESTMENT MANAGEMENT, LLC	0.00%	0.00%	357	357	100.00%	603	Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)	0.13%	0.00%	9,870	791	8.71%	16,680	Jun 30, 2024
ADVISOR GROUP HOLDINGS, INC.	0.04%	-	3,000	3,000	100.00%	5,070	Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC	0.59%	-	44,062	5,196	13.37%	74,464	Jun 30, 2024
SQUAREPOINT OPS LLC	0.17%	-	12,631	12,631	100.00%	21,346	Jun 30, 2024
STATE STREET CORP	0.23%	-	16,800	16,800	100.00%	28,392,000	Jun 30, 2024
VANGUARD GROUP INC	0.43%	-	31,780	31,780	100.00%	53,708	Jun 30, 2024
ATRIA WEALTH SOLUTIONS, INC.	0.52%	0.00%	38,413	38,413	100.00%	64,918	Jun 30, 2024
CVI HOLDINGS, LLC	0.75%	0.08%	55,462	55,462	100.00%	93,731	Jun 30, 2024
MORGAN STANLEY	0.80%	-	59,805	59,805	100.00%	101,070	Jun 30, 2024

As of Jun 30 2024, Nexalin's biggest institutional seller is UBS GROUP AG. The company sold -0.13K shares of NXL, valued at $6.82K.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
MORGAN STANLEY	0.80%	-	59,805	59,805	100.00%	101,070	Jun 30, 2024
CVI HOLDINGS, LLC	0.75%	0.08%	55,462	55,462	100.00%	93,731	Jun 30, 2024
ATRIA WEALTH SOLUTIONS, INC.	0.52%	0.00%	38,413	38,413	100.00%	64,918	Jun 30, 2024
VANGUARD GROUP INC	0.43%	-	31,780	31,780	100.00%	53,708	Jun 30, 2024
STATE STREET CORP	0.23%	-	16,800	16,800	100.00%	28,392,000	Jun 30, 2024
SQUAREPOINT OPS LLC	0.17%	-	12,631	12,631	100.00%	21,346	Jun 30, 2024
ADVISOR GROUP HOLDINGS, INC.	0.04%	-	3,000	3,000	100.00%	5,070	Jun 30, 2024
STONE HOUSE INVESTMENT MANAGEMENT, LLC	0.00%	0.00%	357	357	100.00%	603	Jun 30, 2024
BANK OF AMERICA CORP /DE/	0.00%	-	46	46	100.00%	78	Jun 30, 2024

Nexalin's largest new institutional shareholder by number of shares is MORGAN STANLEY, purchased 59.80K shares, valued at $101.07K, as of undefined.

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
WELLS FARGO & COMPANY/MN	-	-	-	-44	-100.00%	-	Jun 30, 2024

Nexalin's largest sold out institutional shareholder by shares sold is WELLS FARGO & COMPANY/MN, sold -44.00 shares, valued at -, as of undefined.

Nexalin Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
FIDELITY CONCORD STREET TRUST	0.00%	38,866	-	-	Feb 29, 2024

Nexalin's largest mutual fund holder by % of total assets is "FIDELITY CONCORD STREET TRUST", owning 38.87K shares, compromising 0.00% of its total assets.

Nexalin Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
30 Jun, 24	13	160.00%
31 Mar, 24	5	66.67%
31 Dec, 23	3	-40.00%
30 Sep, 23	5	25.00%
30 Jun, 23	4	-42.86%
31 Mar, 23	7	-
31 Dec, 22	7	250.00%
30 Sep, 22	2	-

As of 30 Jun 24, 13 institutions are holding Nexalin's shares, representing an increase of 160.00% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
30 Jun, 24	276,263	335.29%
31 Mar, 24	63,466	32.28%
31 Dec, 23	47,980	-40.94%
30 Sep, 23	81,246	558.50%
30 Jun, 23	12,338	-78.61%
31 Mar, 23	57,671	30.39%
31 Dec, 22	44,230	125.39%
30 Sep, 22	19,624	-

Nexalin (NXL) has 276.26K shares outstanding as of 30 Jun 24, up 335.29% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
30 Jun, 24	3.71%	510.07%
31 Mar, 24	0.85%	203.86%
31 Dec, 23	0.65%	52.04%
30 Sep, 23	1.11%	3889.55%
30 Jun, 23	0.17%	27.02%
31 Mar, 23	0.79%	125.63%
31 Dec, 22	0.79%	554.41%
30 Sep, 22	0.38%	-

As of 30 Jun 24, Nexalin is held by 3.71% institutional shareholders, representing a 510.07% growth compared to 31 Mar 24.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
30 Jun, 24	12	200.00%
31 Mar, 24	4	100.00%
31 Dec, 23	2	-60.00%
30 Sep, 23	5	400.00%
30 Jun, 23	1	-75.00%
31 Mar, 23	4	-42.86%
31 Dec, 22	7	250.00%
30 Sep, 22	2	-

12 institutional shareholders have increased their position in NXL stock as of 30 Jun 24 compared to 4 in the previous quarter (a 200.00% increase).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
30 Jun, 24	1	-
31 Mar, 24	-	-
31 Dec, 23	-	-
30 Sep, 23	-	-100.00%
30 Jun, 23	2	-
31 Mar, 23	2	-
31 Dec, 22	-	-
30 Sep, 22	-	-

1 institutional shareholders have reduced their position in NXL stock as of 30 Jun 24 compared to - in the previous quarter (a 0.00% increase).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
30 Jun, 24	13	160.00%	276,263	335.29%	3.71%	510.07%	12	200.00%	1	-
31 Mar, 24	5	66.67%	63,466	32.28%	0.85%	203.86%	4	100.00%	-	-
31 Dec, 23	3	-40.00%	47,980	-40.94%	0.65%	52.04%	2	-60.00%	-	-
30 Sep, 23	5	25.00%	81,246	558.50%	1.11%	3889.55%	5	400.00%	-	-100.00%
30 Jun, 23	4	-42.86%	12,338	-78.61%	0.17%	27.02%	1	-75.00%	2	-
31 Mar, 23	7	-	57,671	30.39%	0.79%	125.63%	4	-42.86%	2	-
31 Dec, 22	7	250.00%	44,230	125.39%	0.79%	554.41%	7	250.00%	-	-
30 Sep, 22	2	-	19,624	-	0.38%	-	2	-	-	-

Nexalin Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Aug 15, 2024	Owens David	director, officer	Chief Medical Officer	P-Purchase	Buy	1,000	$0.95	$950.00	147,793
Jul 01, 2024	Owens David	director, officer	Chief Medical Officer	P-Purchase	Buy	1,000	$1.75	$1.75K	146,793
Jun 21, 2024	Owens David	director, officer	Chief Medical Officer	P-Purchase	Buy	1,619	$0.71	$1.15K	145,793
Jun 12, 2024	Owens David	director, officer	Chief Medical Officer	P-Purchase	Buy	1,000	$0.62	$620.00	144,174
Jun 12, 2024	Owens David	director, officer	Chief Medical Officer	P-Purchase	Buy	2,000	$0.65	$1.30K	143,174
Oct 05, 2023	White Mark	director, officer	President/CEO	P-Purchase	Buy	25,000	$4.15	$103.75K	25,000
Oct 05, 2023	Owens David	director, officer	Chief Medical Officer	P-Purchase	Buy	2,500	$4.15	$10.38K	2,500
Oct 05, 2023	Kazden Alan	director	-	P-Purchase	Buy	2,500	$4.15	$10.38K	2,500
Oct 05, 2023	Elson Marilyn	10 percent owner, officer	Ms. Elson serves as CFO	P-Purchase	Buy	9,500	$4.15	$39.42K	109,500
Jun 30, 2023	Morad Rick	director	-	P-Purchase	Buy	2,500	$4.15	$10.38K	108,341
Jun 30, 2023	White Mark	director, officer	President/CEO	P-Purchase	Buy	25,000	$4.15	$103.75K	309,127
Jun 30, 2023	Kazden Alan	director	-	P-Purchase	Buy	2,500	$4.15	$10.38K	83,131
Sep 29, 2022	Elson Marilyn	10 percent owner, officer	Ms. Elson serves as CFO	P-Purchase	Buy	9,500	$1.12	$10.64K	835,244
Sep 22, 2022	White Mark	director, officer	President/CEO	P-Purchase	Buy	25,000	$4.15	$103.75K	289,627
Sep 20, 2022	Elson Marilyn	10 percent owner, officer	Ms. Elson serves as CFO	P-Purchase	Buy	36,000	$4.15	$149.40K	825,744

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Aug 15, 2024	Owens David	director, officer	Chief Medical Officer	P-Purchase	Buy	1,000	$0.95	$950.00	147,793
Jul 01, 2024	Owens David	director, officer	Chief Medical Officer	P-Purchase	Buy	1,000	$1.75	$1.75K	146,793
Jun 21, 2024	Owens David	director, officer	Chief Medical Officer	P-Purchase	Buy	1,619	$0.71	$1.15K	145,793
Jun 12, 2024	Owens David	director, officer	Chief Medical Officer	P-Purchase	Buy	1,000	$0.62	$620.00	144,174
Jun 12, 2024	Owens David	director, officer	Chief Medical Officer	P-Purchase	Buy	2,000	$0.65	$1.30K	143,174
Oct 05, 2023	White Mark	director, officer	President/CEO	P-Purchase	Buy	25,000	$4.15	$103.75K	25,000
Oct 05, 2023	Owens David	director, officer	Chief Medical Officer	P-Purchase	Buy	2,500	$4.15	$10.38K	2,500
Oct 05, 2023	Kazden Alan	director	-	P-Purchase	Buy	2,500	$4.15	$10.38K	2,500
Oct 05, 2023	Elson Marilyn	10 percent owner, officer	Ms. Elson serves as CFO	P-Purchase	Buy	9,500	$4.15	$39.42K	109,500
Jun 30, 2023	Morad Rick	director	-	P-Purchase	Buy	2,500	$4.15	$10.38K	108,341
Jun 30, 2023	White Mark	director, officer	President/CEO	P-Purchase	Buy	25,000	$4.15	$103.75K	309,127
Jun 30, 2023	Kazden Alan	director	-	P-Purchase	Buy	2,500	$4.15	$10.38K	83,131
Sep 29, 2022	Elson Marilyn	10 percent owner, officer	Ms. Elson serves as CFO	P-Purchase	Buy	9,500	$1.12	$10.64K	835,244
Sep 22, 2022	White Mark	director, officer	President/CEO	P-Purchase	Buy	25,000	$4.15	$103.75K	289,627
Sep 20, 2022	Elson Marilyn	10 percent owner, officer	Ms. Elson serves as CFO	P-Purchase	Buy	36,000	$4.15	$149.40K	825,744

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source
Jun 30, 2023	Morad Rick	director	-		Sell	-	-	-	105,841
Jun 30, 2023	Hu Ben	director	-		Sell	-	-	-	161,470

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Aug 15, 2024	Owens David	director, officer	Chief Medical Officer	P-Purchase	Buy	1,000	$0.95	$950.00	147,793
Jul 01, 2024	Owens David	director, officer	Chief Medical Officer	P-Purchase	Buy	1,000	$1.75	$1.75K	146,793
Jun 21, 2024	Owens David	director, officer	Chief Medical Officer	P-Purchase	Buy	1,619	$0.71	$1.15K	145,793
Jun 12, 2024	Owens David	director, officer	Chief Medical Officer	P-Purchase	Buy	1,000	$0.62	$620.00	144,174
Jun 12, 2024	Owens David	director, officer	Chief Medical Officer	P-Purchase	Buy	2,000	$0.65	$1.30K	143,174
Oct 05, 2023	White Mark	director, officer	President/CEO	P-Purchase	Buy	25,000	$4.15	$103.75K	25,000
Oct 05, 2023	Owens David	director, officer	Chief Medical Officer	P-Purchase	Buy	2,500	$4.15	$10.38K	2,500
Oct 05, 2023	Kazden Alan	director	-	P-Purchase	Buy	2,500	$4.15	$10.38K	2,500
Oct 05, 2023	Elson Marilyn	10 percent owner, officer	Ms. Elson serves as CFO	P-Purchase	Buy	9,500	$4.15	$39.42K	109,500
Jun 30, 2023	Morad Rick	director	-	P-Purchase	Buy	2,500	$4.15	$10.38K	108,341
Jun 30, 2023	White Mark	director, officer	President/CEO	P-Purchase	Buy	25,000	$4.15	$103.75K	309,127
Jun 30, 2023	Kazden Alan	director	-	P-Purchase	Buy	2,500	$4.15	$10.38K	83,131
Jun 30, 2023	Morad Rick	director	-		Sell	-	-	-	105,841
Jun 30, 2023	Morad Rick	director	-		Buy	-	-	-	61,785
Jun 30, 2023	Hu Ben	director	-		Sell	-	-	-	161,470
Jun 30, 2023	Hu Ben	director	-		Buy	-	-	-	3,582
Jun 30, 2023	Hu Ben	director	-		Buy	-	-	-	584
Sep 29, 2022	Elson Marilyn	10 percent owner, officer	Ms. Elson serves as CFO	P-Purchase	Buy	9,500	$1.12	$10.64K	835,244
Sep 22, 2022	White Mark	director, officer	President/CEO	P-Purchase	Buy	25,000	$4.15	$103.75K	289,627
Sep 20, 2022	Elson Marilyn	10 percent owner, officer	Ms. Elson serves as CFO	P-Purchase	Buy	36,000	$4.15	$149.40K	825,744

The last insider sell of Nexalin's stock was made by Morad Rick on Jun 30 2023, selling - shares at - per share (valued at -). The last insider buy of NXL was made by Owens David on Aug 15 2024, buying 1,000 shares at $0.95 per share (worth $950.00).

Nexalin Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q3 2024	1	-	-
Q2 2024	4	-	-
Q3 2022	15	2	750.00%
Q2 2007	-	38	-
Q1 2007	11	1	1100.00%
Q4 2006	4	2	200.00%
Q3 2006	6	11	54.55%
Q2 2006	11	11	100.00%
Q1 2006	9	3	300.00%
Q4 2005	5	3	166.67%
Q3 2005	32	1	3200.00%
Q2 2005	6	-	-
Q1 2005	5	2	250.00%
Q4 2004	15	25	60.00%
Q3 2004	4	2	200.00%
Q2 2004	7	3	233.33%
Q1 2004	5	1	500.00%
Q4 2003	5	7	71.43%
Q3 2003	6	11	54.55%
Q2 2003	3	1	300.00%

1 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Nexalin's insiders, as of Q3 2024.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q3 2024	1	-	-
Q2 2024	4	-	-
Q3 2022	15	-	-
Q2 2007	-	-	-
Q1 2007	-	-	-
Q4 2006	-	-	-
Q3 2006	-	7	-
Q2 2006	-	6	-
Q1 2006	-	-	-
Q4 2005	-	1	-
Q3 2005	-	-	-
Q2 2005	-	-	-
Q1 2005	-	-	-
Q4 2004	-	13	-
Q3 2004	-	-	-
Q2 2004	-	1	-
Q1 2004	-	-	-
Q4 2003	-	5	-
Q3 2003	-	7	-
Q2 2003	-	-	-

As of Q3 2024, Insider owners conducted 1 open market buy trades and 0 open market sell trades of Nexalin's stocks.

Nexalin Peer Ownership

Ticker	Company
AIMD	Ainos, Inc.
INVO	INVO Bioscience, Inc.
LNSR	LENSAR, Inc.
SSKN	STRATA Skin Sciences, Inc.
MODD	Modular Medical, Inc.
IRIX	IRIDEX Corporation
NPCE	NeuroPace, Inc.
SRDX	Surmodics, Inc.
LIVN	LivaNova PLC
KIDS	OrthoPediatrics Corp.
OSA	ProSomnus, Inc. Common Stock
AZYO	Elutia Inc.
BJDX	Bluejay Diagnostics, Inc.
MOTS	Motus GI Holdings, Inc.

NXL Ownership FAQ

Who Owns Nexalin?

Nexalin is owned by institutional shareholders (3.71%), insiders (14.56%), and public (81.73%). The largest institutional shareholder of Nexalin is MORGAN STANLEY (0.80% of total shares) and the top mutual fund owner is FIDELITY CONCORD STREET TRUST (0.00% of total shares).

Who are the major institutional shareholders of Nexalin?

Nexalin's major institutional shareholders are MORGAN STANLEY, CVI HOLDINGS, LLC, GEODE CAPITAL MANAGEMENT, LLC, ATRIA WEALTH SOLUTIONS, INC., and VANGUARD GROUP INC. The top five shareholders own together 3.09% of the company's share outstanding.

How many Nexalin shareholders are there?

As of Jun 2024, there are 13 institutional shareholders of Nexalin.

What percentage of Nexalin is owned by MORGAN STANLEY?

MORGAN STANLEY owns 59.8K shares of Nexalin, representing 0.80% of the company's total shares outstanding, valued at $101.07K (as of Jun 2024).

What percentage of Nexalin is owned by CVI HOLDINGS, LLC?

As of Jun 2024, CVI HOLDINGS, LLC holds 55.46K shares of Nexalin (NXL), compromising 0.75% of the company, valued at $93.73K.

What percentage of Nexalin is owned by GEODE CAPITAL MANAGEMENT, LLC?

GEODE CAPITAL MANAGEMENT, LLC is the third largest holder of Nexalin. The company owns 44.06K of the company's shares outstanding (worth $74.46K).